
đ How to Use the Archive Search
Use the search bar below to explore the National Citizens Archive. This is a powerful tool designed to help you quickly locate specific information across reports, transcripts, videos, and exhibits.
â
Tips for Best Results:
-
Search by keywords or phrases
Enter a single word (e.g., vaccine, mandates, Charter) or a phrase (e.g., informed consent, adverse events). -
Use specific terms
The more precise your search, the more relevant your results will be. Try names, topics, or key terms from testimony. -
Try different variations
If you don’t find what you’re looking for, try synonyms or alternate wording. -
Results include multiple content types
Your search may return matches from reports, witness transcripts, video pages, and other archive materials. -
Results are ranked by relevance
The most relevant matches will appear first.
âł Please Be Patient
This archive contains a very large volume of content, including thousands of pages of testimony and documentation.
-
Initial results may take a few moments to load
-
If results appear incomplete, allow additional time for the search to fully populate
-
You can refine your search at any time to narrow results
đĄ Helpful Tip
Once you open a document (such as a transcript or report), you can use your browser’s Find function (Ctrl+F or Cmd+F) to quickly locate specific words within that page.
Search this site
837 results found with an empty search
- NCI-R-02-Item-3-1 | National Citizens Ar
3. National Citizens Inquiury 3.0. National Citizens Inquiry 3.1 Public Confidence in Government-Led Public Inquiries Introduction Government-led public inquiries can play a crucial role in investigating significant events and emerging issues of public concern. Formally known as Royal Commissions, these types of inquiries have been around for some time. Historically, the intent of government-led inquiries was to uncover the truth, hold individuals accountable, and to inform public policy. The confidence of the public in the integrity and effectiveness of these inquiries is vital for national success. More recently, Canadians began questioning the validity of government inquiries. This stems from the reluctance of governments to listen to issues of public concern in a fair and unbiased manner. Instead, it is widely believed that many public inquires are simply for show, utilized to satisfy certain legislative requirements. This may explain why Canadians have become disillusioned by governments carefully choreographing the agenda to reach a predetermined and government beneficial conclusion. Often these inquiries are staffed with government insiders and/or people invited to participate, even though in some circumstances there exists the appearance of conflicts of interest. The latter in and of itself provides Canadians with legitimate reasons not to trust their public institutions. Further, without the presence of an objective and unbiased media, the perception is that these public inquiries are generally used to smooth over government failures, indiscretions, conflicts of interest, and outright wrong-doing. Therefore, government-led public inquiries are often seen as susceptible to bias or political interference, particularly when these inquiries are initiated or overseen by more superior governing authorities. Skepticism arises if there are concerns that the inquiryâs findings and recommendations may be influenced or manipulated to protect certain interests or, conversely, to avoid political or legal consequences. Most of all, government-led public inquiries are expected to be independent and free from external influence. However, when doubts of impartiality arise, inevitably public trust erodes. The same complaint can be linked to transparency. People expect their voices to be heard. If there are doubts about the impartiality and independence of the commissioners or panel members leading the inquiry, public trust will be eroded. Perceptions of conflicts of interest or close ties to the entities being investigated can also undermine confidence in the inquiry process. Stated differently, this provides reasons why government-led public inquiries face criticism, particularly if the scope or terms of reference are perceived as too narrow or limited. By the same token, if the inquiry fails to address all relevant aspects of an issue or excludes certain key stakeholders, the public may question the thoroughness and fairness of the investigation. It is from these perspectives, and more, that public trust diminishes when there is a perception that the findings and recommendations of the inquiry are not adequately acted upon or implemented. If there is a lack of accountability for those responsible for the issues under investigation, it can reinforce the perception that the inquiry was a superficial exercise without meaningful consequences. Extended inquiry processes with frequent delays can undermine public trust. If an inquiry drags on for an excessive amount of time without clear progress, it may be viewed as an attempt to prolong or avoid uncomfortable findings. Lengthy processes can also lead to public fatigue and a diminished sense of the inquiryâs importance or relevance. In recent years, government-mandated inquiries have not effectively addressed the concerns of citizens, leading to increased skepticism and diminished confidence in the effectiveness and impact of future inquiries. Public apathy is also a problem since there is a perception that even a negative ruling against the government will simply go unaddressed. It is not enough for a responsible party to simply make an apology in public for unethical or illegal behaviour. Business as usual cannot be the result. In recent times, both federal and provincial governments have failed to address many of these factors. Governments have been ineffective in restoring public confidence. Governments have also failed to demonstrate the importance of truth-seeking, accountability, and effectively informing public policy decisions. Given the current level of public mistrust in government-led public inquiries, it is essential to address these concerns by ensuring transparency, independence, inclusivity, effective communication, and timely implementation of recommendations through a completely independent and citizen-led inquiry. Should government decide to restore public confidence, it will involve a long process of action rather than propaganda. However, if it is the desire of the Canadian people to restore the accountability of their government, they must insist on the following five foundational requirements for any future government-led public inquiry: Transparency Transparency is a cornerstone of public confidence in government-led public inquiries. The process should be open, accessible, and free from hidden agendas or opaque-led decision-making. Transparency ensures that the public has a clear understanding of the inquiryâs objectives, procedures, and findings. Timely release of information, public access to hearings or proceedings, and the publication of inquiry reports are essential components of transparency. When the public can see that an inquiry is conducted in a transparent manner, it enhances their trust in the process and its outcomes. Independence Independence is another critical factor in fostering public confidence in government-led public inquiries. An inquiry must be perceived as free from undue influence or interference. Independent commissioners or panel members, appointed through a transparent and accountable process, help establish this perception. It is important that those leading the inquiry have the necessary expertise and impartiality to investigate the matter at hand. Independence ensures that the inquiryâs findings and recommendations are not compromised by political or external pressures, which strengthens public trust in the process. Inclusivity Inclusivity is key to instilling confidence in government-led public inquiries. The involvement of affected individuals, communities, experts, and relevant stakeholders in the inquiry process is essential. Inclusive participation allows diverse perspectives to be heard, fosters public trust, and ensures the inquiryâs conclusions are comprehensive and well-rounded. Engaging with those affected by the issues under investigation demonstrates a commitment to fairness, empathy, and transparency, further enhancing public confidence in the inquiry. Effective Communication Effective communication is crucial in maintaining public confidence in government-led public inquiries. Clear and regular communication about the inquiryâs progress, objectives, and key milestones helps the public stay informed and engaged. This includes providing updates on the inquiryâs findings, explaining the rationale behind decisions, and addressing any concerns or questions from the public. Open and transparent communication builds credibility and demonstrates the inquiryâs commitment to serving the public interest. Implementation of Recommendations The implementation of recommendations arising from a government-led public inquiry is essential to maintaining public confidence. When the findings and recommendations of an inquiry are promptly and effectively acted upon, it demonstrates that the inquiry was not merely a symbolic exercise but an opportunity for meaningful change. Government commitment to implementing the recommendations sends a strong signal to the public that the inquiry had a real impact and that the government is responsive to the concerns identified during the inquiry process. Conclusion Public confidence in government-led public inquiries is crucial for the legitimacy, effectiveness, and impact. Transparency, independence, inclusivity, effective communication, and the implementation of recommendations are key elements that contribute to building and sustaining public confidence. When these factors are prioritized, the public can trust that government-led public inquiries are conducted in an impartial, fair, and accountable manner. Public confidence ensures that the inquiries serve their intended purpose, which is to uncover the truth, hold accountable those responsible, and inform policies and actions to prevent similar issues in the future. 3.2 The Need for an Independent Inquiry An independent inquiry was necessary for a variety of reasons, including the following: The Canadian public no longer has confidence in the government conducting objective and impartial investigations into significant events or issues. By removing potential biases and conflicts of interest, independent inquiries can provide a fair assessment of the facts and circumstances surrounding potentially contentious public matters. Only a truly independent inquiry could build public trust and confidence in the investigation process. When an inquiry is perceived as unbiased and free from external influence, the public is more likely to have confidence in its findings and recommendations. An independent inquiry that directly engages the public in locations across Canada is vital in holding individuals, organizations, or institutions accountable for their actions or decisions. By examining evidence, interviewing witnesses, and assessing relevant information, independent inquiries can determine responsibility and ensure transparency in the process. This independent Inquiry has the capacity to identify systemic issues or underlying factors that contribute to significant events or issues. By delving into the root causes, an independent inquiry can provide valuable insights and recommendations to prevent similar incidents from occurring in the future. Through their findings and recommendations, the National Citizens Inquiry has highlighted areas of improvement to guide the development of effective policies, procedures, and regulations. The National Citizens Inquiry hearings served as a mechanism for the public to voice their concerns and restore confidence in institutions or systems that may have been compromised. By conducting a thorough and independent examination of an issue, an inquiry can help restore public trust and demonstrate accountability. The National Citizens Inquiry promotes transparency and upholds democratic values by ensuring that government actions or decisions are subject to scrutiny. They contribute to a transparent and accountable governance system, fostering public participation and ensuring that decisions are made in the best interest of society. Overall, the National Citizens Inquiry was necessary to ensure fairness, accountability, and transparency in investigating significant events or issues. By removing biases and conflicts of interest, independent inquiries play a crucial role in delivering objective findings, promoting public trust, and informing policies to prevent recurrence. Report Content Reader Page đ Note to Readers The content presented on this page has been adapted for online viewing and navigation. Due to formatting limitations within the web display system, certain elementsâsuch as layout, spacing, and visual structureâmay differ slightly from the original report. For the complete and fully formatted version, we encourage you to download the official PDF available on the Report Information page. The PDF reflects the report exactly as it was originally written and published.
- Blyth | National Citizens Ar
Witness Testimony Keywords from Transcript Type 1 diabetes, Lyme disease, vaccine mandate pressure, medical exemption denied, chest tightness, shallow breathing, insomnia onset, psych ward admission, quetiapine treatment, high-dose antipsychotic, blood sugar instability, increased insulin, adverse event reporting, lack of accountability, compensation information absence Included in the Report: Mr. James Blyth Private Citizen Personal Experience Witness ID: NCI-W-148 Hearing Saskatoon Saskatchewan Date: April 22, 2023 Report Inquiry into the Appropriateness and Efficacy of the COVID-19 Response in Canada; November 2023 Main Topic Reported adverse reaction following COVID-19 vaccination and challenges obtaining medical acknowledgment and support. One Line Summary Young man with pre-existing conditions describes prolonged health complications after vaccination and difficulty obtaining medical recognition. Synopsis James Blyth testified that, as a young man with Type 1 diabetes and Lyme disease, he sought medical advice before receiving a COVID-19 vaccine during a period of strict mandates in Saskatchewan. He stated that he was not granted a medical exemption and felt pressure from family and public restrictions to proceed with vaccination. Within days of receiving his first dose, he reported experiencing chest tightness, shallow breathing, body aches, and a sensation of heart irregularity, prompting emergency room visits. He indicated that his concerns were dismissed by attending physicians. He described persistent symptoms over several weeks, followed by severe insomnia that led to multiple emergency visits and eventual admission to a psychiatric ward. There, he was prescribed high-dose quetiapine, reaching 800 milligrams daily, which he stated was necessary to induce sleep. He remained on the medication for approximately three to four months. During this period, he reported significant sedation and functional impairment, as well as worsened blood glucose control requiring increased insulin dosages due to medication side effects. Mr. Blyth stated that a naturopathic physician later suggested the vaccine may have triggered a flare of his Lyme disease, possibly involving brain inflammation, and prescribed antibiotics. He reported gradual improvement and was able to discontinue quetiapine. He testified that his adverse reaction was not formally reported, that he received no information about compensation programs, and that he experienced frustration over what he described as a lack of accountability and acknowledgment from healthcare providers. đ How to Search the Transcript Click the âRead Transcriptâ button to open the witness testimony in your browser. Once the transcript PDF is open, you can search for any word or phrase within the document using your browserâs search feature: Windows: Press Ctrl + F Mac: Press Command (â) + F A small search box will appear. Type the word or phrase you are looking for, and the browser will highlight every occurrence within the transcript. This makes it easy to quickly locate specific topics, names, or statements within the testimony.
- Linard | National Citizens Ar
Detailed Commissioner Report Info Referenced in the Report National Citizens Inquiry (NCI) Investigation: Are Children Safe in Canada April 30, 2025 Report ID: Publication Date No. Of Pages: NCI-R-04 April 30, 2024 1267 May 11, 2023 Report National Citizens Inquiry (NCI) Investigation: Are Children Safe in Canada April 30, 2025 Main Topic Purpose and Need for the NCI The National Citizens Inquiry (NCI) was established in response to growing public concerns over the Canadian governmentâs handling of the COVID-19 event. As the COVID-19 emergency measures unfolded, questions arose regarding the appropriateness and efficacy of the measures implemented, including lockdowns, mandates, and the deployment of COVID-19 âvaccines.â These concerns fuelled the need for a thorough examination of the impact these policies had on health, the economy, on society and civil liberties. The NCI, conceived as an independent and citizen led initiative, sought to comprehensively investigate these issues. Its primary purpose was to provide a platform for individuals and experts to share their experiences, insights, and evidence, in order to uncover the truth, hold authorities accountable, and improve future public health responses. On November 28, 2023, the NCI Commissioners released their comprehensive final report, titled Inquiry into the Appropriateness and Efficacy of the COVID-19 Response in Canada . A year later, on November 28, 2024, a supplemental report was issued as part of the NCIâs ongoing efforts to address new and emerging concerns related to the COVID-19 investigation. Having completed its original mandate of investigating the appropriateness and efficacy of the COVID-19 measures, the NCI expanded its focus. After consulting with a broad range of Canadians, the NCI recognized a significant public concern regarding the current state of children's safety in Canada. Consequently, the NCI undertook a new investigation specifically aimed at evaluating and safeguarding the well-being of children across the country. One Line Summary Heading 2 Synopsis Heading 2
- Klowak | National Citizens Ar
Detailed Commissioner Report Info Referenced in the Report National Citizens Inquiry (NCI) Investigation: Are Children Safe in Canada April 30, 2025 Report ID: Publication Date No. Of Pages: NCI-R-04 April 30, 2024 1267 May 18, 2023 Report National Citizens Inquiry (NCI) Investigation: Are Children Safe in Canada April 30, 2025 Main Topic Purpose and Need for the NCI The National Citizens Inquiry (NCI) was established in response to growing public concerns over the Canadian governmentâs handling of the COVID-19 event. As the COVID-19 emergency measures unfolded, questions arose regarding the appropriateness and efficacy of the measures implemented, including lockdowns, mandates, and the deployment of COVID-19 âvaccines.â These concerns fuelled the need for a thorough examination of the impact these policies had on health, the economy, on society and civil liberties. The NCI, conceived as an independent and citizen led initiative, sought to comprehensively investigate these issues. Its primary purpose was to provide a platform for individuals and experts to share their experiences, insights, and evidence, in order to uncover the truth, hold authorities accountable, and improve future public health responses. On November 28, 2023, the NCI Commissioners released their comprehensive final report, titled Inquiry into the Appropriateness and Efficacy of the COVID-19 Response in Canada . A year later, on November 28, 2024, a supplemental report was issued as part of the NCIâs ongoing efforts to address new and emerging concerns related to the COVID-19 investigation. Having completed its original mandate of investigating the appropriateness and efficacy of the COVID-19 measures, the NCI expanded its focus. After consulting with a broad range of Canadians, the NCI recognized a significant public concern regarding the current state of children's safety in Canada. Consequently, the NCI undertook a new investigation specifically aimed at evaluating and safeguarding the well-being of children across the country. One Line Summary Heading 2 Synopsis Heading 2
- Chisholm | National Citizens Ar
Witness Testimony Keywords from Transcript Paramedic, PTSD, EMDR Treatment Delay, Lockdown Impact on Care, Vaccine Adverse Symptoms, Chest Pain, Shortness of Breath, Hypertension, Myocarditis Concern, Adverse Event Reporting, Vaccine Passport, Healthcare Mandate, EMS Staffing Shortage, Workforce Attrition, Medical Exemption Policy Included in the Report: Mr. Chet Chisholm Paramedic Both (Professional and Personal Experience) Witness ID: NCI-W-009 Hearing Truro Nova Scotia Date: March 16, 2023 Report Inquiry into the Appropriateness and Efficacy of the COVID-19 Response in Canada; November 2023 Main Topic Post-Vaccination Health Symptoms and Impact of Healthcare Mandates on EMS Workforce One Line Summary Paramedic Chet Chisholm testified about delayed PTSD treatment due to lockdowns, health symptoms following vaccination, and the impact of vaccine mandates on EMS staffing and workforce retention. Synopsis Chet Chisholm, a paramedic from Antigonish, Nova Scotia, testified regarding the impact of pandemic restrictions on his mental health treatment and professional career. He described being on leave for PTSD when lockdowns interrupted planned in-person EMDR therapy, which he stated delayed his recovery and ultimately contributed to the loss of his position due to contractual time limits. He testified that after receiving one dose of a COVID-19 vaccine, he experienced persistent fatigue, shortness of breath, chest pain, and repeated emergency room visits, though no definitive diagnosis was made. He stated that no adverse event report was discussed despite the temporal proximity between vaccination and symptoms. Chisholm also described the personal and professional impact of vaccine passport policies and ongoing healthcare mandates, including restrictions on access to services and inability to return to work, and expressed concern about significant paramedic workforce losses within Nova Scotiaâs EMS system. đ How to Search the Transcript Click the âRead Transcriptâ button to open the witness testimony in your browser. Once the transcript PDF is open, you can search for any word or phrase within the document using your browserâs search feature: Windows: Press Ctrl + F Mac: Press Command (â) + F A small search box will appear. Type the word or phrase you are looking for, and the browser will highlight every occurrence within the transcript. This makes it easy to quickly locate specific topics, names, or statements within the testimony.
- Chin | National Citizens Ar
Witness Testimony Keywords from Transcript family physician, preventive health practice, early treatment discussion, ivermectin controversy, hydroxychloroquine debate, informed consent concerns, vaccine risk-benefit analysis, myocarditis incidence, regulatory College pressure, professional investigation threat, patient autonomy advocacy, public health messaging critique, excess mortality concern, data transparency demand, clinical observation reporting Included in the Report: Dr. Justin Chin MD, MSc Physician Both (Expert and Personal Experience) Witness ID: NCI-W-172 Hearing Red Deer Alberta Date: April 27, 2023 Report Inquiry into the Appropriateness and Efficacy of the COVID-19 Response in Canada; November 2023 Main Topic Critique of COVID-19 public health measures, vaccine risk-benefit assessment, regulatory suppression of dissenting physicians, and impact on patient care. One Line Summary Alberta physician testifies about early treatment suppression, vaccine risk concerns, and regulatory actions against dissenting medical professionals. Synopsis Dr. Justin Chin, an Alberta family physician and founder of a preventive health-focused medical practice, testified regarding his opposition to aspects of the COVID-19 public health response. He described early concerns about lockdown harms, limitations on patient access to care, and the dismissal of outpatient early treatment strategies. He stated that he observed clinical outcomes suggesting variable disease severity and questioned uniform public messaging that did not reflect age-stratified risk. Dr. Chin testified that he raised concerns about vaccine risk-benefit calculations, particularly in younger populations, referencing reports of myocarditis and other adverse events. He stated that in his clinical practice he emphasized informed consent discussions and individualized assessment rather than universal recommendations. He expressed concern that public health communications did not adequately communicate uncertainty or evolving data and that dissenting scientific viewpoints were marginalized. He further testified that his public statements and prescribing practices drew scrutiny from regulatory authorities, creating what he described as a chilling effect among physicians. He stated that professional investigations and policy directives discouraged open debate and limited physiciansâ ability to discuss alternative treatments or express skepticism regarding mandates. Dr. Chin concluded that restoring public trust would require transparency in data reporting, protection of medical freedom of speech, and re-centering healthcare on individualized patient care rather than centralized policy enforcement. đ How to Search the Transcript Click the âRead Transcriptâ button to open the witness testimony in your browser. Once the transcript PDF is open, you can search for any word or phrase within the document using your browserâs search feature: Windows: Press Ctrl + F Mac: Press Command (â) + F A small search box will appear. Type the word or phrase you are looking for, and the browser will highlight every occurrence within the transcript. This makes it easy to quickly locate specific topics, names, or statements within the testimony.
- NCI-R-01-Item-1-7 | National Citizens Ar
Were the Covid-19 Vaccines Approved Without Safety or Efficacy Proof? Interim Authorization of Covid-19 Vaccine Introduction The Commission received detailed information about the procedure through which "approval" for COVID-19 vaccines was granted in Canada. According to the testimony, the conventional evaluation and endorsement process for the COVID-19 vaccines was not adhered to by the Canadian Government. Instead, a new process was established whereby Health Canada "authorized" the Covid-19 vaccines under an Interim Order (which was later adopted as a permanent regulation). It is important to understand that the Covid-19 vaccines were never approved under the traditional approval process for drugs in Canada. Under the alternative authorization process, the necessity to establish the safety and efficacy of Covid-19 vaccines through an objective manner appears to have been set aside. Objectively and independently proving the safety and efficacy of any new drug before its introduction into the market is an essential cornerstone of responsible healthcare and public safety. This rigorous requirement serves as a critical safeguard for individuals' well- being, ensuring that potential risks are thoroughly assessed and weighed against the benefits. This principle becomes even more pivotal when the drug is intended for widespread use across all segments of the population. The blanket use of a drug, especially one like the Covid-19 vaccines, necessitates an unassailable foundation of evidence. Rigorous testing, transparent evaluation, and independent verification of safety and efficacy are fundamental to instilling trust among both healthcare professionals and the general public. This approach ensures that medical interventions are based on the most accurate and reliable information available. In the context of a global health crisis, these principles are vital to ensuring that public health measures are not only effective but also respectful of individuals' rights and dignity. It is imperative that all drugs proposed to be released to the public be objectively and independently proven to be both safe and effective. It is for this reason that strict proof of safety and efficacy have been required by our drug approval regulations. The need to prove both safety and efficacy take on particular importance for drugs intended for the entire population, including children and pregnant women. This approach forms the bedrock of responsible medical practice and contributes to a society that values health, science, and the dignity of each person. Testimony Concerning Interim Authorization of Covid-19 Vaccines The following vaccines were authorized by Health Canada under the Interim Order: Pfizer-BioNTech on December 9, 2020 for ages 16 and older, and May 5, 2021 for ages 12-15; Moderna on December 23, 2020 for ages 18 and over and August 27, 2021 for ages 12-17; AstraZeneca on February 26, 2021 for ages 18 and older, and Janssen (Johnson & Johnson) on March 5, 2021 for ages 18 and older. The Commission received testimony from two key witnesses, Shawn Buckley and Deanna McLeod, regarding the procedure through which the authorization of Covid-19 vaccines took place in Canada. The initial authorization of all Covid-19 vaccines was provided under a temporary, Interim Order, which exempted them from the traditional regulations that demand manufacturers to demonstrate objective evidence of safety and effectiveness. The result was that while chief medical officers across the country repeatedly assured Canadians that the Covid-19 vaccines were "safe and effective" - the general Canadian population had no understanding that their authorization process had not required objective proof of safety nor efficacy. Shawn Buckley The Political Approval of the Covid Vaccine: A Constitutional Lawyer's Perspective The normal regulatory process for approving a new drug in Canada is set out in Division 8 of Canada's Food and Drug Regulations (the "Regulationsâ). To receive approval for a new drug in Canada, the Regulations require evidence of both the drug's safety and effectiveness be demonstrated to the Minister of Health. Once evidence of safety and efficacy is provided, the Minister considers whether the benefits outweigh the risks. If evidence of safety and effectiveness has been provided that shows the benefits outweigh the risk, the Minister may grant market approval of a new drug. These first steps of demonstrating safety and effectiveness, before approval, are essential to ensuring that Canadians are not exposed to unknown risks in the name of unknown effectiveness. The Federal Governmentâs creation of the Interim Order required Health Canada to approve the Covid-19 vaccines without proof of either safety or of efficacy which resulted in millions of Canadians taking a new drug whose safety and effectiveness could not be known. The unfortunate result of authorizing the Covid-19 vaccines through the Interim Order (instead of under the traditional approval process under the Regulations) was revealed through NCI testimony â many Canadians were injured or killed, while at the same time the Covid-19 vaccine was revealed not to be effective in preventing infection and transmission nor reducing the severity of illness. The benefit of hindsight demonstrates clearly why the traditional tests under the Regulations are needed for all new drug approvals, and why Canada should not authorize drugs under Interim Orders, even in cases of public health emergencies. The Traditional Drug Approval Process The requirements that must be met to approve a new drug in Canada are found in C.08.002(2) of the Regulations. Of particular importance are high requirements for proof of both safety and efficacy. These are found as follows: C.08.002(2) A new drug submission shall contain sufficient information and material to enable the Minister to assess the safety and effectiveness of the new drug, including the following: detailed reports of the tests made to establish the safety of the new drug for the purpose and under the conditions of use recommended; substantial evidence of the clinical effectiveness of the new drug for the purpose and under the conditions of use recommended[.] Under the traditional approval process in the Regulations the first step is to establish the safety profile of the new drug and demonstrate to the Minister of Health that the drug is safe for use in the human population. The second step is to establish the new drugâs benefit profile, in other words, is it effective, does it work. The third step, although not specifically included in the regulation, is to evaluate the Risk / Benefit profile for the drug. In other words, the regulatory review has to establish that the benefits of using the drug outweigh the risk of using the drug. One cannot satisfy the requirement for a risk/benefit analysis without a complete understanding of the drug's safety and benefit profile. Interim Order: Importation, Sale and Advertising of Drugs in Relation to COVID-19 Instead of following the Regulations, on September 16, 2021, the Minister of Health made an Interim Order exempting all Covid-19 drugs (including Covid-19 vaccines) from the normal review and approval process. The Interim Order was made under section 30.1 of the Food and Drugs Act, R.S.C., 1985, c. F-27, which permits the Minister of Health to make an interim order that overrides normal regulations. The section reads: 30.1 (1) The Minister may make an interim order that contains any provision that may be contained in a regulation made under this Act if the Minister believes that immediate action is required to deal with a significant risk, direct or indirect, to health, safety or the environment. The term âsignificant riskâ is not defined in the Act, nor is there any proportionality built into this section. Thus, there do not appear to be any legislative safeguards or guidelines for when this power to override is used by the Minister of Health. Under this broad power, the Minister made the Interim Order which, rather than requiring significant evidence of safety and efficacy of the Covid-19 vaccines as mandatory requirements for approval, only required the vaccine manufacturers to provide: 3(1) ⊠sufficient information and material to enable the Minister to determine whether to issue the authorization, including ⊠(o) the known information in relation to the quality, safety and effectiveness of the drug. By letting the Minister make a decision based on "known information" about safety and effectiveness, this allowed the Covid-19 vaccines to be authorized in advance of actual knowledge about their safety or effectiveness. The Interim Order attempted to make up for this by having manufacturers promise to do more follow-up research as follows: 3(2) If, at the time an application is initially submitted to the Minister, the applicant is unable to provide information or material referred to in any of paragraphs (1)(g) to (k) and (m) to (o) or that information or material is incomplete, the applicant must include in the initial part of the application a plan as to how and when they will provide the Minister with the missing information or material. However, as will be discussed further below, the Interim Order also prevented the Minister from revoking authorization once given, meaning that the Minister was absolved of the responsibility to protect the public if subsequent safety problems were discovered in the Covid-19 vaccines. It is vital to recognize that when the Interim Order was issued, the Minister of Health at the time had attended Lakehead University, graduating with a Bachelor of Arts, and had received a Master of Public Administration from the University of Victoria. To our understanding, the minister possessed no medical training credentials that we would consider pertinent to making the required determinations under the regulations. Approval of Covid-19 Vaccines was virtually guaranteed under the Interim Order Remarkably, the Interim Order effectively required Health Canada to authorize a Covid-19 vaccine for use in the Canadian population even in the absence of detailed evidence of safety and substantial evidence of efficacy. Section 5 of the Interim Order provides: The Minister must issue an authorization in respect of a Covid-19 drug if the following requirements are met: the applicant has submitted an application to the Minister that meets the requirements set out in subsection 3(1) or 4(2); the applicant has provided the Minister with all information or material, including samples, requested under subsection 13(1) in the time, form and manner specified under subsection 13(2); and the Minister has sufficient evidence to support the conclusion that the benefits associated with the drug outweigh the risks, having regard to the uncertainties relating to the benefits and risks and the necessity of addressing the urgent public health need related to Covid-19. The test set out in (c) above is startling when compared to the traditional test for new drugs under the Regulations. Under the traditional test, evidence of safety and efficacy must be proven. Under the Interim Order, there only needs to be "evidence to support the conclusion" that the benefits outweigh the risks. This does not mean the Minister (i.e., Health Canada) has to be convinced and actually reach the conclusion. If the test was to convince Health Canada, the test would read: the Minister has sufficient evidence to conclude The difference in language is important. Under this test, it appears that a vaccine would have to be authorized as long as there was sufficient evidence to support an argument that the benefits outweighed the risks. In addition, the risk versus benefit test need not be robust, as the Minister is to "have regard" for the "uncertainties" of the benefits and risks. It is not clear how the Minister is expected to perform a risk versus benefit analysis when there is insufficient safety and efficacy evidence to determine true risks versus benefits. It is even more unclear how to perform a risk versus benefit analysis while "having regard to the uncertainties" of the risks versus benefits. Ultimately, the Interim Order reveals that the Minister's priority was the "necessity of addressing the urgent public health need related to Covid-19." The problem, of course, is that under this test, the government placed its perceived "urgent public health need" ahead of safety and efficacy of the Covid-19 vaccines. This appears to be what the Government of Canada actually did. Regardless of whether the need for a drug is urgent, this cannot override a proper assessment of safety, particularly when Canadians are under the impression that a drug has been proven safe. The NCI was not made aware of any public health authority in Canada cautioning Canadians that the vaccines had been authorized without the traditional need to prove their safety. Instead, the Government of Canada was under enormous pressure in the media to secure vaccines and make them available to Canadians. In response, it placed orders for millions of doses from the manufacturers. This placed the Government in a conflict of interest because it had purchased and imported unapproved vaccines while it waited for itself to approve the vaccines. The Interim Order appears to have been designed to ensure that the vaccines would have no problem in receiving authorization. As indicated above, in the traditional drug approval process, chances are not taken. If there is uncertainty about either safety or efficacy, the drug is not approved. There must be strict objective evidence of both safety and efficacy. It must also be objectively clear that the benefits outweigh the risks before a new drug is approved. It can only be objectively clear that the benefits of a drug outweigh the risks when the benefits and risks are objectively known. The test for Covid-19 vaccines abandoned this need for objective certainty. Instead of requiring objective proof of: safety; efficacy, and benefit outweighing risk. The Covid-19 vaccines were authorized under a subjective test which mandated that authorization must be granted if an argument could be made to support the conclusion that the benefits outweighed the risk. The question arises: what if there was evidence that went both ways? In other words, what if there was evidence that pointed towards greater benefits, but there was also evidence that pointed towards risks? Under the Interim Order, it seems the Minister must then take into account the subjective factors of: uncertainty and the urgent public health need for a vaccine. This cannot be an appropriate standard for approving a drug that the Government intends to administer to the entire population. It is difficult to conceive of a less-scientific test for drug authorization than that found in the Interim Order. The Interim Order also ensured that the authorization of a Covid-19 vaccine could not be revoked: due to evidence the vaccine was unsafe or not-effective; due to assessments the benefits did not outweigh the risks. This resulted from the fact that once a vaccine was authorized under the Interim Order, most of the Regulations did not apply, including C.08.006. This particular regulation is the safeguard that allows the Minister of Health to cancel a drugâs market authorization if evidence is uncovered that the drug is not safe. Instead, the Interim Order contained its own vague safeguards allowing for cancellation only in a few limited circumstances. The exclusion of the Ministerâs normal powers to revoke authorization, and the reliance on more restricted revocation powers under the Interim Order means that Canadians could not have confidence that the Covid-19 vaccines would be pulled from the market if there was evidence that they were not safe. This situation persisted for roughly a year. Were the Covid-19 Vaccines Approved Without Safety or Efficacy Proof? In addition to the Interim Order, Health Canada created a document called "Guidance for market authorization requirements for Covid-19 vaccines." This document is intended to provide guidance to pharmaceutical companies applying for market authorization. As it must, it follows the new subjective test for the vaccines. For example, the current version includes: About market authorizations for a Covid-19 vaccine Health Canada will grant authorizations only if we determine that the benefits of the vaccine outweigh its potential risks. We will base our decision on the evidence provided on the vaccine's safety, quality and efficacy. For vaccines relying on the modified requirements in C.08.002 (2.1) of the Food and Drug Regulations, the risk- benefit analysis weighs the uncertainties about a potential vaccine against the public health need for a vaccine at the time of the decision. Modified requirements for Covid-19 drugs make it possible for initial authorization, based on early data, while the manufacturer continues working on developing a vaccine. We will use terms and conditions to manage uncertainties or risk mitigation measures related to the vaccine in the context of public health. The NCI heard testimony that the Health Canada employee who authorized all of the Covid-19 vaccines swore an Affidavit for a lawsuit for Federal Court File No. T-145-22 in which she described the basis of Health Canada's authorization of the Pfizer/ BioNTech and Moderna vaccines. Instead of setting out the evidence relied on in support of the authorization, she simply parrots the words of the test. In the case of Pfizer/ BioNTech, she stated that Health Canada reviewed "quality (chemistry and manufacturing), non-clinical (pharmacology and toxicology), and clinical (immunogenicity, safety, and efficacy) information" and then concluded that "the evidence supports the conclusion that the benefits associated with the Pfizer.BioNTech COVID.19 Vaccine outweigh the risks, having regard to a shorter term (median of 2 months) follow up of safety and efficacy at authorization, and the necessity of addressing the urgent public need related to COVID.19." In the case of Moderna, she stated similarly that: "the evidence supported the conclusion that the benefits associated with the Moderna COVID.19 Vaccine outweighed the risks, having regard to a shorter term (median of 2 months) follow up of safety and efficacy at authorization, and the necessity of addressing the urgent public health need related to COVID.19." Notably, what she does not cite in support of the vaccine authorization is: objective proof of safety; objective proof of efficacy, and objective proof that the benefits outweigh the risks. Based on testimony to the NCI, and without further evidence from Health Canada, we cannot conclude that Health Canada properly evaluated the safety and efficacy of the Covid-19 vaccines before authorization. To the contrary, the authorization of the vaccines appears to have been all but pre-assured by the creation of the Interim Order. The Interim Order Has Become Permanent The Interim Order can only last for a maximum of one year. The Interim Order, therefore, was replaced on March 18, 2021, with permanent regulations that codify the subjective authorization test discussed above. The only notable change between the test in the Interim Order and the new permanent regulation is that the "public health need" that needs to be addressed is no longer described as urgent. Recall that the Interim Order required an examination of risks and benefits, while: âhaving regard to âthe necessity of addressing the urgent public health need related to Covid-19" Now the test simply requires Health Canada to give consideration to âthe public health need related to Covid-19.â Thus, under the permanent test, Health Canada no longer has to be swayed by urgency, but simply by the public health need related to Covid-19. In this way, it seems that so long as Covid-19 is a circulating virus, Health Canada must authorize any vaccine for which there is an argument to support the conclusion that its benefits outweigh its risks. In effect, we fear that there will never be a need for Covid-19 vaccine manufacturers to prove safety or efficacy of their products. On a positive note, the NCI heard that the Minister's ability to revoke authorization of Covid-19 vaccines is now subject to the same regular rules as other drugs that are approved for the market. It does beg the question, however, of why was that particular rule modified for Covid-19 vaccines in the first place? Conflict of Interests for the Approval of Experimental Vaccines Canada normally prohibits drugs from being imported into Canada unless they have been approved by Health Canada for use in humans. Despite this, the Interim Order allowed unapproved and unauthorized Covid-19 vaccines to be imported into Canada as long as the Canadian Government was the purchaser. This was called pre-positioning in the Interim Order, and later in the Regulations codifying the Interim Order. The rationale was to assist Canada in expediting its response to the perceived Covid-19 crisis, by pre-purchasing and distributing the vaccines so they would be ready as soon as they were authorized. However, this created a tremendous conflict of interest. Once the vaccines were purchased, imported and ready for distribution, the Government of Canada would have suffered significant political blowback if it was unable to authorize them. Thus, it needed to authorize the Covid-19 vaccines, and it needed to do it quickly. The Government of Canada essentially put itself in charge of authorizing a drug that it had spent millions of public dollars on, had promised publicly on many occasions, and that it wanted to administer to every Canadian citizen. The authorization of the Covid-19 vaccines was all but guaranteed. The Government of Canada ordered the vaccines, imported them, created new regulations to authorize them, and then took significant measures to convince and coerce every Canadian to take multiple doses. The political stakes were high, and the federal government had every motivation to get the vaccines authorized, regardless of their actual efficacy or safety. There was no opportunity for sober second thought. There was no impartial oversight. The entire authorization process appears to have been "gamed" for one result, and one result only: authorization of vaccines for every Canadian, including children. Once the federal Government made mass-vaccination its priority, it should no longer have been solely responsible for their authorization. Timing of the Interim Order The timing of the Interim Order is also curious and coincident. Notably, the September 16, 2020 Interim Order was created just two weeks before AstraZeneca's authorization application was filed with Health Canada, and just three weeks before Pfizer filed on October 8, 2020. Since the authorization applications were made under the Interim Order, they would have been structured to meet the requirements of the Interim Order. Perhaps an authorization application is a standard document, however, the NCI suspects that it would be difficult for a company to prepare a detailed authorization application without knowing what the authorization requirements were going to be. For this reason, there are further questions that need to be answered about how the applications could have been filed so quickly in a manner that satisfied the subjective test, and whether there was participation in creating, or knowledge of the contents of, the test in advance. Phase Three Trial Data Alleged Manipulation of Data Deana McLeod Insights into Covid Vaccine Approval and Trials Deana McLeod's testimony has raised important concerns about the means and methods used in testing Covid-19 vaccines. Her testimony primarily centred on potential conflicts of interest and biases within the teams responsible for conducting and reporting Phase Three test data, which was submitted to Health Canada. Additionally, McLeod shed light on Pfizer's historical legal issues and the broader issue of potential conflicts of interest within the regulatory and approval sector. Her testimony echoed Mr. Shawn Buckley's prior statement that objective tests demonstrating safety and efficacy were omitted from these products. Financial incentives at various stages of the testing and authorization process were also discussed, prompting the need for a thorough examination of motivations. McLeod's testimony serves as a reminder of the importance of transparency, objectivity, and independence in the testing and approval of medical products, especially when it concerns a global health crisis. The potential for conflicts of interest and biases within such a critical process can erode public trust and compromise the credibility of the regulatory framework. The reference to Pfizer's past legal issues underscores the necessity for scrutinizing the track record of pharmaceutical companies involved in the development of vaccines or drugs. The public has a right to be informed about any potential historical shortcomings or ethical concerns that might impact the reliability of the products in question. The removal of objective safety and efficacy tests from the products raises alarming questions about the standards applied to these vaccines. Rigorous testing is the cornerstone of any vaccine's credibility and the foundation of public trust. Omitting such tests potentially undermines the credibility of the entire testing and approval process. The mention of financial motivations at various levels of testing and approval emphasizes the need for greater transparency and accountability within the industry. The potential for financial incentives to influence decision-making is a cause for concern and demands further investigation to ensure that public health is prioritized over financial gain. Lastly, the allusion to Statistics Canada data provided during the testimony highlights the need for comprehensive, reliable, and complete data when assessing the impact of any medical intervention. It is crucial to base decisions on thorough and unbiased information to ensure the well-being of the population. In conclusion, Deana McLeod's testimony raises vital questions about the processes, motivations, and ethics involved in Covid-19 vaccine testing and authorization. This testimony underscores the necessity for transparent, objective, and unbiased approaches in these critical endeavours. The concerns raised must prompt a broader discussion about regulatory practices, industry accountability, and the integrity of medical interventions in the interest of public health and safety. Conclusions There appeared to be a disconnect between Health Canada messaging concerning vaccine approval and the actual test used for authorization. As indicated above, safety, efficacy and whether the benefits of the vaccines outweighed the risks did not need to be proven under the Interim Authorization process employed by Health Canada. Despite the novel nature of the vaccines â in particular those using mRNA â the pharmaceutical companies did not have to objectively prove their safety and efficacy. It should be noted that the special authorization process created under the Interim Order was not mandatory, and pharmaceutical companies still had the option to apply for approval under the regular test which required objective proof of safety, efficacy and cost/ benefit. The pharmaceutical companies did not choose to objectively prove safety, efficacy and cost/benefit. They chose to apply under the Interim Order test, and regulators did not require it of them. Of great concern is the disconnect between Health Canada's public messaging about the Covid-19 vaccines as safe and effective when the regulatory authorization process clearly does not require these be objectively demonstrated. Health Canada continues to message to the public that the regular drug approval requirements of safety and efficacy were met. For example, at the top of Health Canadaâs website page for the Pfizer vaccine, Health Canada states: All Covid-19 vaccines authorized in Canada are proven safe, effective and of high quality [emphasis in the original]. Recommendations Newly implemented revisions to the Food and Drug Regulations related to the authorization of Covid-19 vaccines must be rescinded as they permanently exempt Covid-19 vaccines from the requirements to objectively prove the Safety or Efficacy as required under the Food and Drug Regulations. The current use of Covid-19 vaccines in Canada that were authorized under the revised provisions of the Interim Order and the newly revised Food and Drug Regulations, should be stopped immediately. A full judicial investigation of the process under which the Covid-19 vaccinations were authorized in Canada must be carried out. Criminal liability, if discovered, may be dealt with under existing Canadian law. All documentation concerning the authorization process and information provided to the regulatory agencies by the manufacturers should be made publicly available. Report Content Reader Page đ Note to Readers The content presented on this page has been adapted for online viewing and navigation. Due to formatting limitations within the web display system, certain elementsâsuch as layout, spacing, and visual structureâmay differ slightly from the original report. For the complete and fully formatted version, we encourage you to download the official PDF available on the Report Information page. The PDF reflects the report exactly as it was originally written and published.
- Paul | National Citizens Ar
Witness Testimony Keywords from Transcript YouTube channel termination, CBC article impact, Brigitte NoĂ«l report, QuĂ©becor journalist interaction, show cancellations, sponsor pressure campaign, shadow banning claim, naturopathy association allegation, Bernard Lachance controversy, boycott restaurant impact, radio airplay refusal, Bill C-11 concerns, artistic community silence, social media harassment, income loss donations Included in the Report: Ms. AmĂ©lie Paul Artist Personal Experience Witness ID: NCI-W-240 Hearing QuĂ©bec City QuĂ©bec Date: May 12, 2023 Report Inquiry into the Appropriateness and Efficacy of the COVID-19 Response in Canada; November 2023 Main Topic Professional cancellation, media defamation, and social media censorship following her public criticism of COVID-19 health measures through comedic videos and interviews. One Line Summary A Quebec artist recounts professional and social repercussions, including media reports and platform bans, after producing satirical content critical of pandemic measures. Synopsis AmĂ©lie Paul, a Quebec singer, actress, and online content creator, testified that at the outset of the COVID-19 lockdowns in March 2020, her performance bookings were cancelled and she began producing satirical videos highlighting what she perceived as inconsistencies in public health messaging. One early video, titled âEleven Ways to Weaken Your Immune System,â went viral and led her to continue creating comedic commentary and conducting interviews with alternative voices. She stated that her content drew social media criticism and that several videos were removed by YouTube for violating community guidelines related to criticism of health measures. In June 2021, following the death of her friend Bernard Lachance, she was the subject of a CBC article and news report that she testified portrayed her as his naturopath and implied involvement in his health decisions. She denied these characterizations and stated she was not given an opportunity to publicly defend herself. She reported that following the articleâs publication, her two YouTube channels were terminated, scheduled music performances were cancelled after sponsor pressure, her musicians withdrew from her band, and she experienced reputational harm, harassment, and boycott campaigns affecting her personal circle. Paul further testified that she abandoned her limited naturopathic practice due to fear of regulatory complaints and that radio stations declined to play her music after the controversy. She now relies primarily on public donations and limited online advertising revenue. In her view, open media debate was absent during the crisis, and she expressed concern that legislation such as Bill C-11 could increase online content control. She described ongoing reluctance within the artistic community to publicly dissent due to perceived career risks and funding structures tied to media and government institutions. đ How to Search the Transcript Click the âRead Transcriptâ button to open the witness testimony in your browser. Once the transcript PDF is open, you can search for any word or phrase within the document using your browserâs search feature: Windows: Press Ctrl + F Mac: Press Command (â) + F A small search box will appear. Type the word or phrase you are looking for, and the browser will highlight every occurrence within the transcript. This makes it easy to quickly locate specific topics, names, or statements within the testimony.
- Shaw | National Citizens Ar
Detailed Commissioner Report Info Referenced in the Report National Citizens Inquiry (NCI) Investigation: Are Children Safe in Canada April 30, 2025 Report ID: Publication Date No. Of Pages: NCI-R-04 April 30, 2024 1267 May 2, 2023 Report National Citizens Inquiry (NCI) Investigation: Are Children Safe in Canada April 30, 2025 Main Topic Purpose and Need for the NCI The National Citizens Inquiry (NCI) was established in response to growing public concerns over the Canadian governmentâs handling of the COVID-19 event. As the COVID-19 emergency measures unfolded, questions arose regarding the appropriateness and efficacy of the measures implemented, including lockdowns, mandates, and the deployment of COVID-19 âvaccines.â These concerns fuelled the need for a thorough examination of the impact these policies had on health, the economy, on society and civil liberties. The NCI, conceived as an independent and citizen led initiative, sought to comprehensively investigate these issues. Its primary purpose was to provide a platform for individuals and experts to share their experiences, insights, and evidence, in order to uncover the truth, hold authorities accountable, and improve future public health responses. On November 28, 2023, the NCI Commissioners released their comprehensive final report, titled Inquiry into the Appropriateness and Efficacy of the COVID-19 Response in Canada . A year later, on November 28, 2024, a supplemental report was issued as part of the NCIâs ongoing efforts to address new and emerging concerns related to the COVID-19 investigation. Having completed its original mandate of investigating the appropriateness and efficacy of the COVID-19 measures, the NCI expanded its focus. After consulting with a broad range of Canadians, the NCI recognized a significant public concern regarding the current state of children's safety in Canada. Consequently, the NCI undertook a new investigation specifically aimed at evaluating and safeguarding the well-being of children across the country. One Line Summary Heading 2 Synopsis Heading 2
- Brauti | National Citizens Ar
Witness Testimony Keywords from Transcript federal vaccine mandate, religious accommodation denial, leave without pay, EI appeal success, Social Security Tribunal, Privacy Act request, human rights complaint, Indigenous discrimination claim, MĂ©tis identity, union grievance process, remote work accommodation, financial hardship impact, employment termination dispute, accommodation policy review, workplace fairness concerns Included in the Report: Ms. Suzanne Brauti Federal Public Servant Personal Experience Witness ID: NCI-W-191 Hearing Red Deer Alberta Date: April 28, 2023 Report Inquiry into the Appropriateness and Efficacy of the COVID-19 Response in Canada; November 2023 Main Topic Denial of religious accommodation under the federal COVID-19 vaccine mandate and subsequent employment, financial, and legal consequences. One Line Summary Federal employee describes religious exemption denial, unpaid leave, successful EI appeal, and ongoing human rights complaint following vaccine mandat Synopsis Suzanne Brauti testified that she began working for the federal government in July 2019 after overcoming significant personal and medical challenges as a single mother of three. During the pandemic, she completed her training remotely and worked from home for approximately one year. When the federal COVID-19 vaccine policy was implemented on October 29, 2021, she submitted multiple affidavits requesting a religious accommodation. Despite three submissions and participation in additional meetings, her request was denied in March 2022 after she had already been placed on leave without pay. She applied for Employment Insurance and was initially denied, first on the basis that she voluntarily left her employment and later for alleged misconduct. She appealed to the Social Security Tribunal and testified that she ultimately succeeded after nine months, based on the timing of her employerâs decision. She also filed a Privacy Act request and received approximately 800 pages of correspondence, which she stated revealed inconsistencies, premature assumptions about placing her on unpaid leave, and what she perceived to be inadequate consideration of her accommodation request. She subsequently filed a human rights complaint, alleging discriminatory treatment related to her MĂ©tis identity and the handling of Indigenous-related considerations in the accommodation process. Brauti described significant emotional, financial, and professional consequences, including the loss of her employment, depletion of savings, sale of property, ongoing debt, and strain on her family. After federal mandates were lifted in July 2022, she was informed she would need to reapply and undergo the hiring process again rather than being reinstated. She stated that she believed remote work could have been reasonably accommodated and that the employer failed to demonstrate undue hardship in denying her request. đ How to Search the Transcript Click the âRead Transcriptâ button to open the witness testimony in your browser. Once the transcript PDF is open, you can search for any word or phrase within the document using your browserâs search feature: Windows: Press Ctrl + F Mac: Press Command (â) + F A small search box will appear. Type the word or phrase you are looking for, and the browser will highlight every occurrence within the transcript. This makes it easy to quickly locate specific topics, names, or statements within the testimony.
- Tissen | National Citizens Ar
Detailed Commissioner Report Info Referenced in the Report National Citizens Inquiry (NCI) Investigation: Are Children Safe in Canada April 30, 2025 Report ID: Publication Date No. Of Pages: NCI-R-04 April 30, 2024 1267 April 13, 2023 Report National Citizens Inquiry (NCI) Investigation: Are Children Safe in Canada April 30, 2025 Main Topic Purpose and Need for the NCI The National Citizens Inquiry (NCI) was established in response to growing public concerns over the Canadian governmentâs handling of the COVID-19 event. As the COVID-19 emergency measures unfolded, questions arose regarding the appropriateness and efficacy of the measures implemented, including lockdowns, mandates, and the deployment of COVID-19 âvaccines.â These concerns fuelled the need for a thorough examination of the impact these policies had on health, the economy, on society and civil liberties. The NCI, conceived as an independent and citizen led initiative, sought to comprehensively investigate these issues. Its primary purpose was to provide a platform for individuals and experts to share their experiences, insights, and evidence, in order to uncover the truth, hold authorities accountable, and improve future public health responses. On November 28, 2023, the NCI Commissioners released their comprehensive final report, titled Inquiry into the Appropriateness and Efficacy of the COVID-19 Response in Canada . A year later, on November 28, 2024, a supplemental report was issued as part of the NCIâs ongoing efforts to address new and emerging concerns related to the COVID-19 investigation. Having completed its original mandate of investigating the appropriateness and efficacy of the COVID-19 measures, the NCI expanded its focus. After consulting with a broad range of Canadians, the NCI recognized a significant public concern regarding the current state of children's safety in Canada. Consequently, the NCI undertook a new investigation specifically aimed at evaluating and safeguarding the well-being of children across the country. One Line Summary Heading 2 Synopsis Heading 2
- Ditzel | National Citizens Ar
Detailed Commissioner Report Info Referenced in the Report National Citizens Inquiry (NCI) Investigation: Are Children Safe in Canada April 30, 2025 Report ID: Publication Date No. Of Pages: NCI-R-04 April 30, 2024 1267 May 4, 2023 Report National Citizens Inquiry (NCI) Investigation: Are Children Safe in Canada April 30, 2025 Main Topic Purpose and Need for the NCI The National Citizens Inquiry (NCI) was established in response to growing public concerns over the Canadian governmentâs handling of the COVID-19 event. As the COVID-19 emergency measures unfolded, questions arose regarding the appropriateness and efficacy of the measures implemented, including lockdowns, mandates, and the deployment of COVID-19 âvaccines.â These concerns fuelled the need for a thorough examination of the impact these policies had on health, the economy, on society and civil liberties. The NCI, conceived as an independent and citizen led initiative, sought to comprehensively investigate these issues. Its primary purpose was to provide a platform for individuals and experts to share their experiences, insights, and evidence, in order to uncover the truth, hold authorities accountable, and improve future public health responses. On November 28, 2023, the NCI Commissioners released their comprehensive final report, titled Inquiry into the Appropriateness and Efficacy of the COVID-19 Response in Canada . A year later, on November 28, 2024, a supplemental report was issued as part of the NCIâs ongoing efforts to address new and emerging concerns related to the COVID-19 investigation. Having completed its original mandate of investigating the appropriateness and efficacy of the COVID-19 measures, the NCI expanded its focus. After consulting with a broad range of Canadians, the NCI recognized a significant public concern regarding the current state of children's safety in Canada. Consequently, the NCI undertook a new investigation specifically aimed at evaluating and safeguarding the well-being of children across the country. One Line Summary Heading 2 Synopsis Heading 2








